The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

The United States has deep ties to its southern neighbors. The Trump administration's efforts to wield its economic and ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease and offered meaningful results in DESTINY-Breast04. In a 2025 real-world ...

Rosalía made an album invoking the saints, Lily Allen took us on a tragicomic trip through her domestic hell, Lady Gaga found ...

Corbus Pharmaceuticals Holdings, Inc. ( CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data December 11, 2025 8:00 AM EST ...

The answer to “who can save our country?” is in the mirror.

As well as musicians' memoirs, there are also interesting insights on issues such as the rise of Spotify and Berlin's club ...

President Tinubu’s tenure has become a theatre of contradictions, marked not by vision or reform but by failures that expose ...

On our just-published year-end Hot 100 chart, 11 of the top 12 songs were released before 2025, and over half of them even ...

During the quarter, we settled our worldwide patent litigation with Bruker on favorable terms and recognized an upfront ...

Formation Bio has acquired the global rights, excluding in Greater China, to LNK01006, a highly selective tyrosine kinase 2 ...